The Surgical Management of Small Bowel Neuroendocrine Tumors
Year: 2017
Type: article
Abstract: Small bowel neuroendocrine tumors (SBNETs) have been increasing in frequency over the past decades, and are now the most common type of small bowel tumor. Consequently, general surgeons and surgical oncologists are seeing more patients with SBNETs in their practices than ever before. The management of these patients is often complex, owing to their secretion of hormones, frequent presentation with advanced disease, and difficulties with making the diagnosis of SBNETs. Despite these issues, even patients with advanced disease can have long-term survival. There are a number of scenarios which commonly arise in SBNET patients where it is difficult to determine the optimal management from the published data. To address these challenges for clinicians, a consensus conference was held assembling experts in the field to review and discuss the available literature and patterns of practice pertaining to specific management issues. This paper summarizes the important elements from these studies and the recommendations of the group for these questions regarding the management of SBNET patients.
Source: Pancreas
Institutions: University of Iowa, Memorial Sloan Kettering Cancer Center, Oregon Health & Science University, University of Toronto, National Cancer Institute, Winship Cancer Institute, Louisiana State University Health Sciences Center New Orleans, University of Pennsylvania, Emory University, Icahn School of Medicine at Mount Sinai, University of South Florida, Moffitt Cancer Center, University of California, San Francisco, Sunnybrook Health Science Centre
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Cancer Institute
OpenAlex ID: W2626441915